Vasculitis Trial, Recruiting (NCT05935709)

Vasculitis Trial, Recruiting NCT05935709 Sponsor: Aarhus University Hospital Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT05935709 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Giant Cell Arteritis (GCA) or Polymyalgia Rheumatica (PMR) within the last 5 years
Your diagnosis has been made or confirmed by a rheumatologist (a specialist in joint and immune system conditions)
You can speak and understand Danish
You are able to give your signed and dated agreement to take part in the trial

Who may not be able to join:

You are unable or unwilling to give your consent to participate in the trial
You have been diagnosed with another systemic autoimmune disease (a condition where the immune system attacks the body) that rules out a diagnosis of GCA or PMR (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Berit Dalsgaard Nielsen, Ass prof, Led og Bindevæv, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, 8200 Aarhus N, DK

Phone: +4530225709

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05935709

Sponsor: Aarhus University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: +4530225709

More information: https://clinicaltrials.gov/study/NCT05935709

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Giant Cell Arteritis (GCA) or Polymyalgia Rheumatica (PMR) within the last 5 years
Your diagnosis has been made or confirmed by a rheumatologist (a specialist in joint and immune system conditions)
You can speak and understand Danish
You are able to give your signed and dated agreement to take part in the trial

Who may not be able to join:

You are unable or unwilling to give your consent to participate in the trial
You have been diagnosed with another systemic autoimmune disease (a condition where the immune system attacks the body) that rules out a diagnosis of GCA or PMR (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Aarhus University Hospital

Registry

ClinicalTrials.gov

Start date

10 November 2023

Est. completion

31 December 2034

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Cumulative glucocorticoid doses compared between patients with cranial GCA and patients with Large Vessel-GCA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov